Clinical significance of novel biomarkers to predict the natural course of hepatitis B infection

BACKGROUND AND AIM: Chronic hepatitis B (CHB) can be divided into immune tolerance (IT), immune clearance (IC), hepatitis B e antigen (HBeAg)-negative inactive/quiescent carrier (ENQ), and HBeAg-negative hepatitis (ENH) phases. The conventional biomarkers used to distinguish these phases have limita...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Weikang, Yuan, Xiaojie, Zhang, Weilu, Zhou, Haowei, Kong, Xiangyu, He, Zhen, Fu, Ting, Zhang, Wenhua, Jia, Wenling, Liang, Chunhui, Tang, Haitao, Wang, Fengmei, Ye, Yancheng, Shao, Zhongjun, Ji, Zhaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650535/
https://www.ncbi.nlm.nih.gov/pubmed/36388269
http://dx.doi.org/10.3389/fpubh.2022.1037508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650535/
https://www.ncbi.nlm.nih.gov/pubmed/36388269
http://dx.doi.org/10.3389/fpubh.2022.1037508

Ejemplares similares